ZNO 3.85% 2.7¢ zoono group limited

Zoono update

  1. 138 Posts.
    lightbulb Created with Sketch. 10
    Received this as an email

    Zoono Group Limited (ASX:ZNO) | ASX Announcement

     

    Zoono Group Releases New Videos | Products, Investment, Industry

     

    a5d8f742-66f0-4d80-a3cf-6013eb4523c5.png


     

    Zoono Group Limited (ASX:ZNO) is pleased to release new videos featuring our Founder and CEO Paul Hyslop. Paul introduces our global biotech company and explains how we develop, manufacture and distribute a suite of scientifically-validated, long-lasting and environmentally-friendly antimicrobial solutions.
     

    Watch Paul’s introduction to Zoono Group

     Paul also showcases how to use our products and explains how our technology is based on the ‘Zoono Molecule’ - a unique antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mould. 
     

    Watch Paul showcase our products & technology
     
    Zoono Group is committed to building an industry leadership position and Paul outlines how we’ve established a global network of customers and distributors spread across many countries and territories.
     

    Watch Paul outline our global expansion
     
    Zoono Group is founded on technology focussed on long lasting antimicrobial protection products. As an industry expert Paul tells The Capital Network’s Lelde Smits why this emerging industry is set for compelling developments.
     

    Watch Paul detail the global investment opportunity
     
    Subscribe to our YouTube page for recent developments

     

    Corporate Enquiry
    Paul Hyslop
    CEO/Managing Director
    P: + 64 2165 9977
    E:
    [email protected]

    Media Enquiry
    Julia Maguire
    The Capital Network
    P: +61 419 815 386
    E:
    [email protected]

     

    f95de197-65bc-42df-a845-bf05681df848.png

     

    a5c6053f-9ba1-4b13-9097-a010520b9bb5.png

    Zoono is a global biotech company that develops, manufactures and distributes a suite of scientifically-validated, long-lasting and environmentally-friendly antimicrobial solutions. 
     

    Zoono produces aerosol-based sprays suited for skin care, surface sanitisers, and treatments for acne and mould remediation. The products are based on the ‘zoono molecule’, a unique antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mould. 
     

    Zoono’s products have received numerous regulatory approvals and the company’s technology claims are supported by independent testing conducted in laboratories worldwide. Zoono is headquartered in New Zealand and its products are available globally.
     

    To learn more please visit: www.zoono.com 

 
watchlist Created with Sketch. Add ZNO (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.001(3.85%)
Mkt cap ! $9.536M
Open High Low Value Volume
2.7¢ 2.8¢ 2.7¢ $2.214K 79.27K

Buyers (Bids)

No. Vol. Price($)
3 83972 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 65000 1
View Market Depth
Last trade - 15.59pm 12/07/2024 (20 minute delay) ?
ZNO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.